18 years ago, I came to the US to pursue my dream of becoming a scientist. Last week marked a major milestone in this journey, as I accepted an Assistant Professor position at @UChicago, where I am thrilled to start my own research group in January 2025! (1/5)
So grateful to receive this fellowship alongside fellow rockstar scientists! 💪🏻🧬👩🏻🔬Thankful for the support from my mentor @aventura71 and the whole Ventura lab!
Have you been thinking about how to make megabase-sized deletions? Does MACHETE ring a bell, but maybe the details seem daunting? Fret no more, since our protocol has just been published @NatureProtocols! https://t.co/P1OFA1RPqs
@VHIO@MSKCancerCenter
Excited to see this story out-- congrats @EricaJeanPhD!! I was so lucky to work with Erica as an undergrad in @CatherineFreud2's lab. Their support inspired me to pursue a career in research! #mentormoments
Now out in @NatureCancer, an updated version of our study developing the #MACHETE strategy for modeling large genomic deletions and using it to uncover a key role for type I #IFN deletions in tumor #ImmuneEvasion & #Metastasis: https://t.co/ZeYLMvkYb6 (1/3)
New Preprint! Led by #DynamicDuo@BarrigaFM & @KTsanov, this study set out to understand how somatic copy number alterations (CNAs) promote cancer. CNAs are prevalent across cancer types & correlate w/ clinical outcomes but remain difficult to study. 1/n
https://t.co/gKauUVzL0x
Just released @Nature: slide-DNA-seq, our new method for spatial DNA sequencing in tissues 🧬
Excited to add a genetic dimension to the rapidly expanding spatial toolbox with the tech dev superteam of Tongtong Zhao, @JD_Buenrostro & @insitubiology (1/6)
https://t.co/Au1Fe0tOpf
Thrilled to share a pre-print of our latest work on developing a next-generation AT2 organoid system to model lung adenocarcinoma. Thank you to all the contributors! @santi14563@LabJacks@kochinstitute@MIT (🧵 1/5)
https://t.co/wNqYvdUXPl
To most, Gerstner Sloan Kettering Graduate School of Biomedical Sciences' appeal lies in its affiliation with MSK. However, the program isn't strictly focused on cancer research. Far from it, in fact. Hear from GSK alumni as they share their experience. https://t.co/Kt1JWn4CTr
Excited to share our work @LabJacks out @CD_AACR today that identifies the cell-of-origin as a critical determinant of Smarca4-mediated tumor suppression in the lung and shows the direct effects of Smarca4 loss on SWI/SNF and chromatin state during lung cancer evolution. 1/
The LaFave Lab is hiring! We are looking for team members excited about studying chromatin biology in lung cancer. Check out the new lab website for more details: https://t.co/cfKFxYtqJN! Please retweet!